Dynavax Technologies Corp (DVAX)
12.42
+0.06
(+0.49%)
USD |
NASDAQ |
Nov 22, 16:00
12.25
-0.17
(-1.37%)
After-Hours: 20:00
Dynavax Technologies Price: 12.42 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 12.32 | 12.58 | 12.32 | 12.42 | 901981.0 |
Nov 21, 2024 | 12.26 | 12.44 | 12.11 | 12.36 | 1.868M |
Nov 20, 2024 | 12.01 | 12.24 | 11.75 | 12.17 | 1.353M |
Nov 19, 2024 | 11.75 | 12.09 | 11.50 | 12.01 | 1.438M |
Nov 18, 2024 | 12.18 | 12.36 | 11.60 | 11.69 | 3.225M |
Nov 15, 2024 | 13.34 | 13.40 | 12.13 | 12.21 | 8.112M |
Nov 14, 2024 | 13.58 | 13.70 | 13.36 | 13.39 | 2.792M |
Nov 13, 2024 | 13.60 | 13.74 | 13.44 | 13.52 | 1.956M |
Nov 12, 2024 | 13.50 | 13.72 | 13.15 | 13.50 | 3.184M |
Nov 11, 2024 | 13.21 | 13.89 | 13.13 | 13.66 | 7.177M |
Nov 08, 2024 | 12.50 | 13.72 | 12.41 | 13.01 | 5.100M |
Nov 07, 2024 | 12.29 | 12.41 | 12.01 | 12.02 | 2.220M |
Nov 06, 2024 | 12.25 | 12.40 | 12.00 | 12.29 | 3.242M |
Nov 05, 2024 | 11.86 | 12.07 | 11.76 | 12.01 | 2.313M |
Nov 04, 2024 | 11.72 | 11.83 | 11.61 | 11.79 | 1.915M |
Nov 01, 2024 | 11.93 | 11.98 | 11.75 | 11.78 | 1.780M |
Oct 31, 2024 | 12.10 | 12.10 | 11.81 | 11.85 | 1.852M |
Oct 30, 2024 | 11.78 | 12.10 | 11.72 | 12.06 | 2.849M |
Oct 29, 2024 | 11.39 | 11.84 | 11.38 | 11.81 | 3.147M |
Oct 28, 2024 | 10.76 | 11.41 | 10.67 | 11.39 | 3.338M |
Oct 25, 2024 | 10.83 | 11.00 | 10.70 | 10.71 | 1.785M |
Oct 24, 2024 | 10.89 | 10.90 | 10.69 | 10.77 | 2.519M |
Oct 23, 2024 | 11.00 | 11.05 | 10.79 | 10.87 | 1.912M |
Oct 22, 2024 | 11.00 | 11.02 | 10.93 | 10.99 | 7.278M |
Oct 21, 2024 | 11.00 | 11.10 | 10.89 | 10.98 | 2.439M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.27
Minimum
Mar 16 2020
20.94
Maximum
Nov 03 2021
10.56
Average
11.10
Median
Feb 17 2023
Price Benchmarks
Biogen Inc | 157.90 |
Repligen Corp | 142.58 |
West Pharmaceutical Services Inc | 316.59 |
Janux Therapeutics Inc | 50.31 |
XOMA Royalty Corp | 30.20 |
Price Related Metrics
PE Ratio | 95.54 |
PS Ratio | 6.772 |
Price to Book Value | 2.396 |
Price to Free Cash Flow | 77.91 |
Earnings Yield | 1.05% |
Market Cap | 1.633B |
Normalized PE Ratio | 95.54 |